Tonix Pharmaceuticals announced that its CEO, Seth Lederman, will participate in two major investor conferences: the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026, and the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September 16, 2026. These events provide Tonix an opportunity to showcase its commercial-stage biotech developments, including its flagship fibromyalgia drug TONMYA® and other CNS, infectious disease, immunology, and rare disease programs. Investors can access live webcasts and replays on Tonix's website. This participation highlights Tonix's ongoing efforts to engage with investors and promote its pipeline of innovative treatments.
The Bitcoin BLAKE2b fork, which split from Bitcoin in August 2026, is introducing a new rule requiring miners to wait 45 days before spending newly mined coins to prevent network exploitation. This comes after the fork's token, BTCB2, dropped 84% fro...
SAGA Metals Corp. reported significant progress on its two 100%-owned Labrador projects: the Radar Titanium-Vanadium-Iron Project and the Wolverine Heavy Rare Earth Element Project. The Northern Miner, a respected mining publication, conducted site v...
Gold Strike Resources Corp. has joined the Yukon Mining Alliance, a group promoting Yukon as a top mining jurisdiction. This membership will help Gold Strike showcase its Florin Gold Project and other assets in the promising Tombstone Gold Belt, whic...
Hayasa Metals announced a non-binding term sheet for a Strategic Exploration Alliance with a major mining company to explore copper and critical metals in southern Armenia's Tethyan Belt. The alliance, funded by the major miner, aims to identify econ...
Beyond Minerals Inc. completed a private placement of a $50,000 unsecured convertible debenture with 10% interest, convertible into shares at $0.05 each, to fund general working capital. The company also elected to adopt semi-annual financial reporti...
